2 completed, 2 not yet recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Not yet recruiting 2 |
Follow Malaria Infection: new trials by email Literature Review of Malaria Infection trials Research Report on Malaria Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda MMV371, Placebo for MMV371 - Malaria (Plasmodium Falciparum), Malaria Falciparum | Phase 1 | Not yet recruiting | Medicines for Malaria Venture | 80 | 2026-09-01 | 2026-04-23 |
| Experimental Malaria Infection of Healthy Malaria-Naive Adults by Mosquito Bite With the Genetically Modified Plasmodium Falciparum NF54/iGP3 GAP NF54/iGP3 - Malaria Falciparum, Malaria Infection | Phase 1 | Not yet recruiting | University of Melbourne | 2 | 2025-07-01 | 2025-03-18 |
| Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso PfSPZ-LARC2 Vaccine, Normal Saline (Placebo) - Malaria Falciparum, Malaria Infection | Phase 1 | Completed | Sanaria Inc. | 75 | 2025-03-04 | 2026-04-16 |
| Malaria Vaccine for Children in Mali AMA1-C1/Alhydrogel plus CPG 7909 - Malaria, Malaria Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 200 | 2008-08-11 | 2017-07-02 |
Malaria, Falciparum (4) · Malaria (3)
Infections (4) · Mosquito-Borne Diseases (4) · Parasitic Diseases (4) · Protozoan Infections (4) · Vector Borne Diseases (4) · Malaria (1)
ProMune (1) · Saline Solution (1)
Medicines for Malaria Venture (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Sanaria Inc. (1) · University of Melbourne (1)
Australia (1) · Burkina Faso (1) · Mali (1) · Rwanda (1)
James McCarthy (1) · Jean-Claude Sumanyi, PMhH (1)